Neogen (NASDAQ:NEOG) Posts Better-Than-Expected Sales In Q4
Life sciences company Neogen (NASDAQ:NEOG) beat Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $231.3 million. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.